Search research articles
Contact Us
Filters
Showing results (1-10 of 290) with videos related to
Page
of 29
Sort By:
Bailliere'S Clinical Neurology
|
April 2, 1999
Other immunomodulatory therapies in multiple sclerosis
C H Polman
Nederlands Tijdschrift Voor Geneeskunde
|
May 29, 1999
[Interferon beta-1b now also for the relapsing progressive form of multiple sclerosis?]
C H Polman
International MS Journal
|
August 10, 2007
Cytotoxic immune responses mediated by monoclonal antibodies in MS: incorrectly dismissed as ineffective?
J Killestein, C H Polman
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 18, 2006
Anti-myelin antibodies in multiple sclerosis: clinically useful?
C H Polman, J Killestein
Lancet (London, England)
|
August 20, 1994
Cladribine treatment of multiple sclerosis
C H Polman, J C Koetsier
Immunology Today
|
November 14, 1997
Th-cell modulation in multiple sclerosis
R Q Hintzen, C H Polman
Nederlands Tijdschrift Voor Geneeskunde
|
October 27, 1984
[Treatment of trigeminal neuralgia and hemifacial spasm: another viewpoint]
C H Polman, C J Gijsbers
BMJ (Clinical Research Ed.)
|
August 19, 2000
Drug treatment of multiple sclerosis
C H Polman, B M Uitdehaag
Current Opinion in Neurology
|
June 1, 1995
The treatment of multiple sclerosis: current and future
C H Polman, H P Hartung
Nederlands Tijdschrift Voor Geneeskunde
|
December 31, 1994
[Copolymer 1 in the treatment of multiple sclerosis]
C H Polman, J C Koetsier
Page
of 29
Search research articles
Search
Showing results (1-10 of 290) with videos related to
Sort By:
Page
of 29
Bailliere'S Clinical Neurology
|
April 2, 1999
Other immunomodulatory therapies in multiple sclerosis
C H Polman
Nederlands Tijdschrift Voor Geneeskunde
|
May 29, 1999
[Interferon beta-1b now also for the relapsing progressive form of multiple sclerosis?]
C H Polman
International MS Journal
|
August 10, 2007
Cytotoxic immune responses mediated by monoclonal antibodies in MS: incorrectly dismissed as ineffective?
J Killestein, C H Polman
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 18, 2006
Anti-myelin antibodies in multiple sclerosis: clinically useful?
C H Polman, J Killestein
Lancet (London, England)
|
August 20, 1994
Cladribine treatment of multiple sclerosis
C H Polman, J C Koetsier
Immunology Today
|
November 14, 1997
Th-cell modulation in multiple sclerosis
R Q Hintzen, C H Polman
Nederlands Tijdschrift Voor Geneeskunde
|
October 27, 1984
[Treatment of trigeminal neuralgia and hemifacial spasm: another viewpoint]
C H Polman, C J Gijsbers
BMJ (Clinical Research Ed.)
|
August 19, 2000
Drug treatment of multiple sclerosis
C H Polman, B M Uitdehaag
Current Opinion in Neurology
|
June 1, 1995
The treatment of multiple sclerosis: current and future
C H Polman, H P Hartung
Nederlands Tijdschrift Voor Geneeskunde
|
December 31, 1994
[Copolymer 1 in the treatment of multiple sclerosis]
C H Polman, J C Koetsier
Page
of 29